Aller au contenu

The 62nd American Society of Hematology Annual Meeting and Exposition ASH 2020

5 Décembre 2020 · 4 joursSan Diego, Etats-UnisHématologieAnglais
The 62nd American Society of Hematology Annual Meeting and Exposition ASH 2020
San Diego

À propos de ce congrès

With more than 17,000 members from nearly 100 countries, the American Society of Hematology (ASH) is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.

MEDFLIXS couvrira les temps forts de ce congrès sous forme d'interviews vidéo et de best-of disponibles pour les professionnels de santé inscrits.

Vidéos de ce congrès

Monica Bocchia · Peripheral blood CD26+ leukaemia stem cell monitoring in CML during TKI treatment
Lancer la vidéo · Monica Bocchia · Peripheral blood CD26+ leukaemia stem cell monitoring in CML during TKI treatmentInscription gratuite requise pour lancer la lecture

Monica Bocchia · 00:08:45

Adam Cohen · Clinical activity and safety of cevostamab in relapsed/refractory multiple myelomavvvv
Lancer la vidéo · Adam Cohen · Clinical activity and safety of cevostamab in relapsed/refractory multiple myelomavvvvInscription gratuite requise pour lancer la lecture

Adam Cohen · 00:07:35

Simon Harrison · Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma
Lancer la vidéo · Simon Harrison · Novel bispecific T-cell engager molecule shows promise in r/r multiple myelomaInscription gratuite requise pour lancer la lecture

Simon Harrison · 00:05:25

Francesca Gay · Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the random
Lancer la vidéo · Francesca Gay · Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomInscription gratuite requise pour lancer la lecture

Francesca Gay · 00:03:06

Patricio Duarte · Latest advice on the management of multiple myeloma patients
Lancer la vidéo · Patricio Duarte · Latest advice on the management of multiple myeloma patientsInscription gratuite requise pour lancer la lecture

Patricio Duarte · 00:08:24

Robert Rifkin · ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Lancer la vidéo · Robert Rifkin · ASH 2020: Immunotherapy in relapsed/refractory multiple myelomaInscription gratuite requise pour lancer la lecture

Robert Rifkin · 00:28:45

Marivi Mateos · ASH 2020: Targeted therapies in r/r multiple myeloma
Lancer la vidéo · Marivi Mateos · ASH 2020: Targeted therapies in r/r multiple myelomaInscription gratuite requise pour lancer la lecture

Marivi Mateos · 00:21:26

E2E Chen Kumar-ecancer Web
Lancer la vidéo · E2E Chen Kumar-ecancer WebInscription gratuite requise pour lancer la lecture

00:12:45

Elena Zamagni · FORTE Trial: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myeloma
Lancer la vidéo · Elena Zamagni · FORTE Trial: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myelomaInscription gratuite requise pour lancer la lecture

Elena Zamagni · 00:03:52

Mark Hertzberg · B-HOLISTIC study and the importance of r/r Hodgkin lymphoma real world evidence data
Lancer la vidéo · Mark Hertzberg · B-HOLISTIC study and the importance of r/r Hodgkin lymphoma real world evidence dataInscription gratuite requise pour lancer la lecture

Mark Hertzberg · 00:15:40

Ola Landgren · Evaluation of MRD negativity in patients with relapsed or refractory multiple myeloma treated
Lancer la vidéo · Ola Landgren · Evaluation of MRD negativity in patients with relapsed or refractory multiple myeloma treatedInscription gratuite requise pour lancer la lecture

Ola Landgren · 00:06:42

David Teachey · Cranial radiation mostly eliminated in children with T-ALL and bortezomib potentially improves
Lancer la vidéo · David Teachey · Cranial radiation mostly eliminated in children with T-ALL and bortezomib potentially improvesInscription gratuite requise pour lancer la lecture

David Teachey · 00:04:51